109 related articles for article (PubMed ID: 10720138)
1. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide, a therapeutic agent for APL.
Zhang TD; Chen GQ; Wang ZG; Wang ZY; Chen SJ; Chen Z
Oncogene; 2001 Oct; 20(49):7146-53. PubMed ID: 11704843
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia.
Lallemand-Breitenbach V; Guillemin MC; Janin A; Daniel MT; Degos L; Kogan SC; Bishop JM; de Thé H
J Exp Med; 1999 Apr; 189(7):1043-52. PubMed ID: 10190895
[TBL] [Abstract][Full Text] [Related]
4. PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As
Huang X; Yang Y; Zhu D; Zhao Y; Wei M; Li K; Zhu HH; Zheng X
Cell Mol Life Sci; 2022 May; 79(6):319. PubMed ID: 35622143
[TBL] [Abstract][Full Text] [Related]
5. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia.
Guo Z; Meng M; Geng S; Du Z; Zheng Y; Yao J; Li Z; Han G; Lin H; Du G
J Ethnopharmacol; 2017 Jan; 196():29-38. PubMed ID: 27965050
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cells.
Huynh TT; Sultan M; Vidovic D; Dean CA; Cruickshank BM; Lee K; Loung CY; Holloway RW; Hoskin DW; Waisman DM; Weaver ICG; Marcato P
Sci Rep; 2019 Jul; 9(1):9414. PubMed ID: 31263158
[TBL] [Abstract][Full Text] [Related]
7. GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation.
Jensen HA; Bunaciu RP; Varner JD; Yen A
Cell Signal; 2015 Aug; 27(8):1666-75. PubMed ID: 25817574
[TBL] [Abstract][Full Text] [Related]
8. miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia.
Li H; Hou J; Fu Y; Zhao Y; Liu J; Guo D; Lei R; Wu Y; Tang L; Fan S
Ann Hematol; 2023 Dec; 102(12):3357-3367. PubMed ID: 37726492
[TBL] [Abstract][Full Text] [Related]
9. Extracellular signal-regulated kinase 8-mediated NF-κB activation increases sensitivity of human lung cancer cells to arsenic trioxide.
Wu DD; Lau ATY; Yu FY; Cai NL; Dai LJ; Ok Kim M; Jin DY; Xu YM
Oncotarget; 2017 Jul; 8(30):49144-49155. PubMed ID: 28467781
[TBL] [Abstract][Full Text] [Related]
10. Microgranular acute promyelocytic leukemia presenting with leukopenia and an unusual immunophenotype.
McDonnell MH; Smith ET; Lipford EH; Gerber JM; Grunwald MR
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):35-38. PubMed ID: 26806461
[TBL] [Abstract][Full Text] [Related]
11. Spicamycin and KRN5500 induce apoptosis in myeloid and lymphoid cell lines with down-regulation of bcl-2 expression and modulation of promyelocytic leukemia protein.
Zhang WJ; Ohnishi K; Yoshida H; Pan L; Maksumova L; Muratkhodjaev F; Luo JM; Shigeno K; Fujisawa S; Naito K; Nakamura S; Shinjo K; Takeshita A; Ohno R
Jpn J Cancer Res; 2000 Jun; 91(6):604-11. PubMed ID: 10874212
[TBL] [Abstract][Full Text] [Related]
12. Sodium arsenite and arsenic trioxide differently affect the oxidative stress of lymphoblastoid cells: An intricate crosstalk between mitochondria, autophagy and cell death.
Rainey NE; Armand AS; Petit PX
PLoS One; 2024; 19(5):e0302701. PubMed ID: 38728286
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes.
Swindell EP; Hankins PL; Chen H; Miodragović DU; O'Halloran TV
Inorg Chem; 2013 Nov; 52(21):12292-304. PubMed ID: 24147771
[TBL] [Abstract][Full Text] [Related]
14. Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology.
Dawood M; Hamdoun S; Efferth T
Front Pharmacol; 2018; 9():143. PubMed ID: 29535630
[TBL] [Abstract][Full Text] [Related]
15. Metabolism, toxicity and anticancer activities of arsenic compounds.
Khairul I; Wang QQ; Jiang YH; Wang C; Naranmandura H
Oncotarget; 2017 Apr; 8(14):23905-23926. PubMed ID: 28108741
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of apoptosis in acute promyelocytic leukemia cells leads to increases in levels of oxidized protein and LMP2 immunoproteasome.
Khan MA; Oubrahim H; Stadtman ER
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11560-5. PubMed ID: 15284441
[TBL] [Abstract][Full Text] [Related]
17. Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9.
Du Y; Zhang D; Liu H; Lai R
BMC Biotechnol; 2009 Oct; 9():84. PubMed ID: 19804631
[TBL] [Abstract][Full Text] [Related]
18. Ferritin nanovehicle for targeted delivery of cytochrome C to cancer cells.
Macone A; Masciarelli S; Palombarini F; Quaglio D; Boffi A; Trabuco MC; Baiocco P; Fazi F; Bonamore A
Sci Rep; 2019 Aug; 9(1):11749. PubMed ID: 31409839
[TBL] [Abstract][Full Text] [Related]
19. Biological responses to arsenic compounds.
Platanias LC
J Biol Chem; 2009 Jul; 284(28):18583-7. PubMed ID: 19363033
[TBL] [Abstract][Full Text] [Related]
20. No Association of AS3MT Gene Polymorphisms with Susceptibility to Hepatotoxicity in APL Patients Treated with AS2O3: A Single-Center Study.
Joneidi Z; Mortazavi Y; Chahardouli B; Rostami S; Vaezi M; Nabipour M; Biglari A; Ghavamzadeh A
Int J Hematol Oncol Stem Cell Res; 2023 Oct; 17(4):281-290. PubMed ID: 38076777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
